Updated
Updated · PR Newswire · Jul 8
Medical Device Reprocessing Market to Reach $3.8 Billion by 2034 as 8% CAGR Gains Traction
Updated
Updated · PR Newswire · Jul 8

Medical Device Reprocessing Market to Reach $3.8 Billion by 2034 as 8% CAGR Gains Traction

1 articles · Updated · PR Newswire · Jul 8

Summary

  • $3.8 billion is DelveInsight’s 2034 forecast for the global medical device reprocessing market, up from $1.8 billion in 2025 at an expected 8% CAGR.
  • Cost pressure and waste reduction are driving adoption as hospitals and ambulatory centers reuse reprocessed single-use devices to cut procurement spending while meeting safety and performance standards.
  • North America held the largest 2025 share at about 43%, supported by FDA oversight and participation from more than 9,000 hospitals and ambulatory surgical centers; third-party reprocessing is the biggest segment.
  • Asia-Pacific is projected to grow fastest, with a 16.88% CAGR through 2034, as healthcare infrastructure expands and countries including Japan, China and India build regulatory and procurement support.

Insights

How will Asia's rapid growth in device reprocessing reshape the global healthcare supply chain?
As device reprocessing booms, are original manufacturers losing their battle to block this trend?
With reprocessed devices sometimes failing less than new ones, could 'used' become the new standard for safety?